Ars Pharmaceuticals Inc (SPRY)

$12.57 +0.39 (3.20%)
Market Cap 1.18B
Revenue (ttm) 30,000.00
Net Income (ttm) -54.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -181,233.33%
Debt to Equity Ratio 0.00
Volume 1,679,700
Avg Vol 1,320,274
Day's Range N/A - N/A
Shares Out 97.19M
Stochastic %K 85%
Beta 0.96
Analysts Strong Sell
Price Target $29.00

Latest News on SPRY

ARS Pharmaceuticals Files for Approval of neffy® in Canada and the United Kingdom on Behalf of Licensing Partner ALK-Abelló A/S

Jan 6, 2025, 8:00 AM EST - 11 days ago

ARS Pharmaceuticals Files for Approval of neffy® in Canada and the United Kingdom on Behalf of Licensing Partner ALK-Abelló A/S

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies

Dec 19, 2024, 5:25 PM EST - 4 weeks ago

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies

ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia

Dec 12, 2024, 2:32 PM EST - 5 weeks ago

ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia

ARS Pharmaceuticals Announces Planned Launch of neffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost

Dec 4, 2024, 8:00 AM EST - 6 weeks ago

ARS Pharmaceuticals Announces Planned Launch of neffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost

ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 12:40 PM EST - 2 months ago

ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript

ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 13, 2024, 6:30 AM EST - 2 months ago

ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024

Nov 11, 2024, 7:41 AM EST - 2 months ago

ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024

ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States

Nov 11, 2024, 7:00 AM EST - 2 months ago

ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States

ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

Nov 9, 2024, 5:30 PM EST - 2 months ago

ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

ARS Pharmaceuticals, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 4, 2024, 11:00 AM EST - 2 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

Nov 3, 2024, 11:00 AM EST - 2 months ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

ARS Pharmaceuticals, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 2, 2024, 11:00 AM EDT - 2 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Shareholders To Join An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

Oct 31, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Encourages Shareholders To Join An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

ARS Pharmaceuticals, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

Oct 30, 2024, 11:00 AM EDT - 2 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

Oct 24, 2024, 8:30 AM EDT - 3 months ago

ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

ARS Pharmaceuticals, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Reach Out To The Schall Law Firm

Oct 23, 2024, 11:00 AM EDT - 3 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Reach Out To The Schall Law Firm

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

Oct 19, 2024, 11:00 AM EDT - 3 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Oct 17, 2024, 11:00 AM EDT - 3 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Related Infractions

Oct 8, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Related Infractions

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

Oct 6, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm

Oct 5, 2024, 11:00 AM EDT - 3 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

Oct 4, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Assist The Schall Law Firm

Oct 3, 2024, 11:00 AM EDT - 3 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Assist The Schall Law Firm

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 3 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Contact The Schall Law Firm

Sep 29, 2024, 11:00 AM EDT - 3 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Contact The Schall Law Firm

The Schall Law Firm Urges Stockholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

Sep 28, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Urges Stockholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Investors Are Invited To Assist The Schall Law Firm

Sep 27, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Investors Are Invited To Assist The Schall Law Firm

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

Sep 24, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Should Contact The Schall Law Firm

Sep 23, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Should Contact The Schall Law Firm

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc's Securities Law Violations

Sep 22, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc's Securities Law Violations

The Schall Law Firm Urges Stockholders To Join An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

Sep 20, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Urges Stockholders To Join An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

ARS Pharmaceuticals, Inc. May Have Committed Securities Fraud And Investors With Losses Should Contact The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. May Have Committed Securities Fraud And Investors With Losses Should Contact The Schall Law Firm

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc For Securities Law Violations And Affected Shareholders Are Urged To Reach Out

Sep 18, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc For Securities Law Violations And Affected Shareholders Are Urged To Reach Out

ARS Pharmaceuticals, Inc. May Have Committed Securities Fraud And The Schall Law Firm Wants Investors To Help With An Inquiry

Sep 17, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. May Have Committed Securities Fraud And The Schall Law Firm Wants Investors To Help With An Inquiry

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc For Securities Related Infractions And Shareholders Are Invited To Lend A Hand

Sep 16, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc For Securities Related Infractions And Shareholders Are Invited To Lend A Hand

ARS Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Urges Investors To Join An Inquiry

Sep 15, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Urges Investors To Join An Inquiry

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc's Possible Securities Fraud And Stockholders Are Invited To Play A Part

Sep 14, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc's Possible Securities Fraud And Stockholders Are Invited To Play A Part

ARS Pharmaceuticals, Inc. May Have Committed Securities Law Violations And Investors Should Help The Schall Law Firm Investigate

Sep 13, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. May Have Committed Securities Law Violations And Investors Should Help The Schall Law Firm Investigate

The Schall Law Firm Has Launched An Inquiry In ARS Pharmaceuticals Inc's Possible Securities Fraud And Stakeholders Are Urged To Reach Out

Sep 12, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Has Launched An Inquiry In ARS Pharmaceuticals Inc's Possible Securities Fraud And Stakeholders Are Urged To Reach Out

ARS Pharmaceuticals, Inc. Is Being Looked Into For Securities Law Violations And The Schall Law Firm Invites Investors To Take Part

Sep 11, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. Is Being Looked Into For Securities Law Violations And The Schall Law Firm Invites Investors To Take Part

ARS Pharmaceuticals to Participate in the 2024 Cantor Global Healthcare Conference

Sep 10, 2024, 4:05 PM EDT - 4 months ago

ARS Pharmaceuticals to Participate in the 2024 Cantor Global Healthcare Conference

Shareholders Can Join The Schall Law Firm In An Investigation Into ARS Pharmaceuticals Inc's Possible Fraud

Sep 10, 2024, 11:00 AM EDT - 4 months ago

Shareholders Can Join The Schall Law Firm In An Investigation Into ARS Pharmaceuticals Inc's Possible Fraud

ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)

Sep 9, 2024, 4:47 PM EDT - 4 months ago

ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)

ARS Pharmaceuticals, Inc. Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Urges Investors To Reach Out

Sep 9, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Urges Investors To Reach Out

The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc's Possible Securities Fraud And Shareholders Are Invited To Contribute

Sep 7, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc's Possible Securities Fraud And Shareholders Are Invited To Contribute

ARS Pharmaceuticals, Inc. May Have Violated Securities Regulations And The Schall Law Firm Seeks Investor Participation In An Inquiry

Sep 6, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals, Inc. May Have Violated Securities Regulations And The Schall Law Firm Seeks Investor Participation In An Inquiry

ARS Pharmaceuticals: A Decent Bet For Upside After Neffy Approval

Sep 6, 2024, 4:05 AM EDT - 4 months ago

ARS Pharmaceuticals: A Decent Bet For Upside After Neffy Approval

The Schall Law Firm Is Looking Into Whether ARS Pharmaceuticals Inc Committed Securities Law Violations And Stockholders Are Urged To Join The Investigation

Sep 5, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether ARS Pharmaceuticals Inc Committed Securities Law Violations And Stockholders Are Urged To Join The Investigation

ARS Pharmaceuticals Inc. May Have Defrauded The Public And The Schall Law Firm Wants Impacted Investors To Reach Out About An Inquiry

Sep 4, 2024, 11:00 AM EDT - 4 months ago

ARS Pharmaceuticals Inc. May Have Defrauded The Public And The Schall Law Firm Wants Impacted Investors To Reach Out About An Inquiry

The Schall Law Firm Is Looking Into Whether ARS Pharmaceuticals Inc Committed Securities Related Infractions And Shareholders Are Urged To Help

Sep 3, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether ARS Pharmaceuticals Inc Committed Securities Related Infractions And Shareholders Are Urged To Help